Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Corneal stromal dissection after intrastromal injection of bevacizumab in metaherpetic corneal neovascularization

Poster Details

First Author: C. Sanz-Pozo SPAIN

Co Author(s):    J. Peraza-Nieves   P. Cifuentes-Canorea   M. Sastre-Ibanez   N. Avalos-Franco   G. Arcos-Villegas   R. Mendez-Fernandez     

Abstract Details

Purpose:

To describe a potential complication during intrastromal injection of Bevacizumab in a patient with lipoid deposition secondary to corneal neovascularization.

Setting:

Hospital ClĂ­nico San Carlos de Madrid. Tertiary referal center.

Methods:

A 44 years old male came to the emergency room complaining of 'white spot' on right eye (OR) and blurred vision without pain during last year. The patient had previous history of herpetic keratitis. Best corrected visual acuity (BCVA) was 0.8 in OR. Biomicroscopy showed a superior paracentral mid-stromal opacification in OR with deep stromal lipid deposition secondary neovascularization superiorly. Intrastromal and yuxtalimbal subconjunctival injections of Bevacizumab 1.25 mg/0.05 mL were indicated. While performing the injection an up-to-down lamellar dissection was produced. A 50 % air bubble anterior chamber fulfill was left.

Results:

At First day postoperative control, BCVA was 0.4 which improved to 0.7 with pinhole. Intraocular pressure was normal. Biomicroscopy showed traces of blood at deep stromal lamellar interface. Anterior segment optical coherence tomography ( AS-OCT) showed a 344 microns deep lamellar dissection with a posterior lamella of 100 microns separated by a 128 microns pocket. The patient was treated with tobramycin/dexamethasone 3mg/ml-1mg/ml twice a day. 3 weeks later, the BCVA remained stable and we noticed decrease of the opacity, lipoid deposition and absence of corneal neovascularization. AS-OCT confirmed complete resolution of corneal lamellar dissection.

Conclusions:

A deep stromal lamellar dissection can occur after injecting a small volume of Bevacizumab with complete spontaneous resolution. Bevacizumab may be a good option for treating lipoid deposits and corneal neovascularization as metaherpetic sequelae.

Financial Disclosure:

NONE

Back to Poster listing